The Carcinoembryonic Antigen (CEA) Test is a diagnostic tool used to detect the presence of CEA in the blood. CEA is a protein produced by certain types of cancer cells, and its presence in the blood can indicate the presence of cancer. The CEA Test is used to monitor the progression of cancer, as well as to detect recurrence after treatment. It is also used to detect the presence of certain types of cancer in individuals who have no symptoms. The CEA Test market is a subset of the larger Diagnostics market, which includes a wide range of tests used to diagnose and monitor diseases. The CEA Test market is a growing segment of the Diagnostics market, as it is increasingly used to detect and monitor cancer. Some companies in the CEA Test market include Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, and Quest Diagnostics. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
